Kewalramani Reshma bought VRTX
May 24, 2024 · Form 4 insider transaction
Kewalramani Reshma bought 1,565 shares of Vertex Pharmaceuticals Incorporated at $187.53 per share, a transaction worth $293.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,565
Price
$187.53
Total value
$293.5K
InsiderKewalramani Reshma
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 24, 2024
Filing dateMay 29, 2024
Shares owned after122,939
OwnershipDirect
10b5-1 planNo
AmendedNo